Key2Meds Information

Key2Meds | Unlocking What’s Next in your Biotech's Innovation At Key2Meds, we deliver integrated R&D solutions that help biotech companies accelerate discovery, optimize development, and bring life-changing therapies to market faster. Our end-to-end solutions connect every stage of the drug discovery and preclinical development journey — from chemistry and pharmacology to biologics and peptide screening. Whether you’re advancing small molecules or biologics, our adaptable platforms and expert teams are built to scale with your science. 🔹 Accelerate results — streamline timelines and control R&D costs 🔹 Enable breakthroughs — translate discovery into development with precision 🔹 Empower innovation — leverage expertise across chemistry, DMPK, pharmacology, biologics, and specialty models With state-of-the-art facilities, proven best practices, and a commitment to quality, speed, agility, and value — Key2Meds gives you the keys to unlock your biotech potential. Key2Meds specializes in consulting, product development through contract research organizations, and customer support for drug discovery and development. We tailor our services to fit the needs of both small- and large-molecule biotech companies, helping them grow and succeed in R&D. We provide your company with complete R&D packages or a la carte services as needed to enable your discoveries by providing: • GLP/non-GLP NHP toxicology • Chemistry - Synthetic chemistry for small molecule synthesis and scale up • DMPK - Drug deposition, metabolism, and pharmacokinetics • Pharmacology - In vitro and in vivo pharmacology • Animal Models - Specialty animal models in oncology, CNS, and other indications • Biologics discovery - VHH/Nanobody Our KEY advantages: Quality, speed, agility, and value.